Goldman Sachs’s Colgate-Palmolive CL Stock Holding History

Goldman Sachs’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,000	Closed	-$3.95M	–	6545
2025 Q4	$3.95M	Hold	50,000	–	–	﹤0.01%	3959
2025 Q3	$4M	Hold	50,000	–	–	﹤0.01%	3855
2025 Q2	$4.54M	Hold	50,000	–	–	﹤0.01%	3520
2025 Q1	$4.68M	Buy	+50,000	New	+$4.48M	﹤0.01%	3420
2024 Q3	–	Sell	-12,800	Closed	-$1.24M	–	5848
2024 Q2	$1.24M	Buy	+12,800	New	+$1.18M	﹤0.01%	4301
2023 Q1	–	Sell	-25,000	Closed	-$1.97M	–	5949
2022 Q4	$1.97M	Sell	25,000 -286,400	-92%	-$21.5M	﹤0.01%	3957
2022 Q3	$21.9M	Buy	311,400 +77,200	+33%	+$6.05M	0.01%	1784
2022 Q2	$18.8M	Buy	+234,200	New	+$18.3M	﹤0.01%	1948
2021 Q3	–	Sell	-19,500	Closed	-$1.59M	–	6251
2021 Q2	$1.59M	Hold	19,500	–	–	﹤0.01%	4403
2021 Q1	$1.54M	Buy	19,500 +3,600	+23%	+$282K	﹤0.01%	4252
2020 Q4	$1.36M	Sell	15,900 -142,200	-90%	-$11.8M	﹤0.01%	4000
2020 Q3	$12.2M	Sell	158,100 -3,200	-2%	-$244K	﹤0.01%	2149
2020 Q2	$11.8M	Sell	161,300 -73,200	-31%	-$5.2M	﹤0.01%	2137
2020 Q1	$15.6M	Sell	234,500 -7,500	-3%	-$529K	0.01%	1716
2019 Q4	$16.7M	Buy	242,000 +155,700	+180%	+$10.6M	﹤0.01%	2019
2019 Q3	$6.34M	Buy	86,300 +3,000	+4%	+$218K	﹤0.01%	2681
2019 Q2	$5.97M	Sell	83,300 -80,600	-49%	-$5.72M	﹤0.01%	2731
2019 Q1	$11.2M	Sell	163,900 -42,900	-21%	-$2.77M	﹤0.01%	2319
2018 Q4	$12.3M	Sell	206,800 -193,800	-48%	-$12.1M	﹤0.01%	2186
2018 Q3	$26.8M	Sell	400,600 -16,600	-4%	-$1.11M	0.01%	1701
2018 Q2	$27M	Buy	417,200 +2,900	+0.7%	+$190K	0.01%	1663
2018 Q1	$29.7M	Sell	414,300 -1,140,200	-73%	-$82.1M	0.01%	1532
2017 Q4	$117M	Sell	1,554,500 -392,700	-20%	-$28.7M	0.03%	719
2017 Q3	$142M	Sell	1,947,200 -1,224,700	-39%	-$88.3M	0.03%	601
2017 Q2	$235M	Buy	3,171,900 +690,300	+28%	+$51.3M	0.06%	339
2017 Q1	$182M	Buy	2,481,600 +2,264,600	+1,044%	+$159M	0.05%	420
2016 Q4	$14.2M	Sell	217,000 -17,500	-7%	-$1.2M	﹤0.01%	2208
2016 Q3	$17.4M	Buy	234,500 +33,700	+17%	+$2.49M	0.01%	2002
2016 Q2	$14.7M	Sell	200,800 -15,800	-7%	-$1.13M	﹤0.01%	2025
2016 Q1	$15.3M	Sell	216,600 -256,700	-54%	-$17.1M	0.01%	1916
2015 Q4	$31.5M	Sell	473,300 -88,300	-16%	-$5.87M	0.01%	1442
2015 Q3	$35.6M	Sell	561,600 -17,000	-3%	-$1.11M	0.01%	1295
2015 Q2	$37.8M	Sell	578,600 -957,700	-62%	-$65M	0.01%	1323
2015 Q1	$107M	Sell	1,536,300 -260,500	-14%	-$18M	0.03%	610
2014 Q4	$124M	Buy	1,796,800 +748,700	+71%	+$50.6M	0.04%	569
2014 Q3	$68.4M	Buy	1,048,100 +660,200	+170%	+$43.5M	0.02%	854
2014 Q2	$26.4M	Buy	387,900 +94,900	+32%	+$6.36M	0.01%	1576
2014 Q1	$19M	Sell	293,000 -32,600	-10%	-$2.05M	0.01%	1813
2013 Q4	$21.2M	Sell	325,600 -248,500	-43%	-$15.9M	0.01%	1700
2013 Q3	$34M	Sell	574,100 -109,200	-16%	-$6.47M	0.01%	1234
2013 Q2	$39.1M	Buy	+683,300	New	+$40.6M	0.02%	1051

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs's CL Position: Q1 2026 in Review

Goldman Sachs increased its Colgate-Palmolive (CL) stake by 72% in Q1 2026, buying an estimated $355M and bringing the position to 9,475,834 shares worth $808M. The position accounts for 0.09% of the portfolio, ranked #206.

Goldman Sachs first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $894M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Goldman Sachs held 9,475,834 shares of Colgate-Palmolive worth $808M as of Q1 2026.
Goldman Sachs bought 3,982,104 Colgate-Palmolive shares in Q1 2026, an estimated $355M.
Colgate-Palmolive made up 0.09% of Goldman Sachs's portfolio in Q1 2026, its #206 holding.
Goldman Sachs first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
Goldman Sachs's Colgate-Palmolive position peaked at $894M in Q3 2024.
1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.